AbbVie Inc. (ABBV)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Address

1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Founded

2011

Number of Employees

50,000

Website

http://www.abbvie.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 $307,989 $5,815,597 $5,904,220 $503,074 - - - - - - - $3,132,720
Average Price $66.52 $64.88 $62.39 $94.77 - - - - - - - $64.52
# Shares Purchased 4,630,142 89,640,583 94,636,515 5,308,294 - - - - - - - 48,553,884
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date 191.6% 199.0% 211.0% 104.7% - - - - - - - 200.7%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% - - - - - - - 163.3%
Excess Total Return 9.8% 26.1% 42.4% -25.0% - - - - - - - 37.4%
Quartile Rank
Percentile Rank 73% 76% 78% 70% - - - - - - - 93%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
SCHERING PLOUGH CORP

OPGEN INC
ELI LILLY & Co
RICHMOND TIMOTHY J.

AbbVie Inc.
SORG ELAINE K.

AbbVie Inc.